The FDA approved a new drug from Seres Therapeutics that uses bacteria to treat ...
Teladoc beat Wall Street revenue estimates in the 2023’s first quarter — a feat ...
An early-stage Alzheimer’s disease treatment from Alnylam Pharmaceuticals showed...
Few details had been made public about the death of the first patient in a desig...
The mega-deal between Kaiser Permanente and Geisinger marks the biggest proposed...
The House Oversight Committee is going to hold a hearing on the results of an in...
The European Commission unveiled a long-awaited proposed update for how the cont...
rAAV-Olig001 is a new vector from a class of recombinant AAVs (rAAVs) that selec...
Packaging plays a critical part in the pharmaceuticals and medical devices indus...
Adcentrx’s ADRX-0706 is anticipated to enter a first-in-human Phase I clinical t...
VYD222 is being assessed in an ongoing Phase I healthy volunteer clinical trial ...
The Phase III trial taps into a growing trend of digital therapeutics use in neu...
Despite past challenges, the oral drug is now being studied in a global Phase II...
As Singapore’s pharmaceutical industry gains investment, Albatroz completes fina...
Vedanta plans to use the proceeds to support a pivotal Phase III trial of VE303 ...
INB-400 will be evaluated in a Phase II clinical trial in newly diagnosed gliobl...
